USBio Logo

C2254-87P1 Mouse Anti-CD3 (PE-Cy5), CD4 (PE), CD8 (FITC), Triple Color

Specifications
References
Clone Type
Monoclonal
Host
Mouse
Source
Human
Conjugate
PE-Cy5/PE/FITC
Isotype
IgG2a
Clone Number
S4.1/S3.5/3B5
Grade
Purified
Applications
FC
Crossreactivity
Hu
Shipping Temp
Blue Ice
Storage Temp
-20°C

CD3/CD4/CD8 combination is a fluorescent reagent containing mouse anti-human of CD3, CD4 and CD8 monoclonal antibodies conjugated to the tandem fluorochrome PE-Cy5, phycoerythrin, and fluorescein, respectively. This reagent permits the simultaneous identification of CD3+ mature T lymphocytes, CD4+ helper/inducer T lymphocytes and CD8+ suppressor/cytotoxic T lymphocytes in human peripheral blood by flow cytometric methods.

CD3 monoclonal antibody recognizes the CD3 antigen. The monoclonal antibody may be used to enumerate mature T lymphocytes in human peripheral blood. This monoclonal antibody may also be used, in combination with other indicators, for the monoclonal antibody recognizes the CD3 antigen. May be used to enumerate mature T lymphocytes in human peripheral blood. May also be used, in combination with other indicators, for the diagnosis or prognosis of some immunodeficiency diseases, including agammaglobulinemia and the severe combined immunodeficiency disease (SCID), which exhibit decreased percentages of T lymphocytes. CD4 monoclonal antibody recognizes the CD4 antigen. This antibody may be used, in combination with other indicators, for the diagnosis or prognosis of immunodeficiency diseases, including hypogammaglobulinemia, severe combined immunodeficiency (SCID) and the acquired immunodeficiency disease (AIDS). The CD4 antigen domain is generally recognized to contain the binding site for the HIV retrovirus through interaction with the viral envelope glycoprotein.
The major cellular or cell-derived elements of human peripheral blood include lymphocytes, monocytes, granulocytes, red blood cells and platelets. The mature lymphocyte population contains functionally distinct cell types that are referred to as T (thymus-derived), B and NK (Natural Killer) cells. Two major subsets of T lymphocytes have distinctly different functional properties, and can be identified by correspondingly different cell surface glycoprotein antigens (1). The CD3+ mature T lymphocytes expressing the CD4 surface antigen are responsible for helper-inducer activity, while CD3+ cells that express the CD8 antigen have suppressor and cytotoxic activity (2).
CD3 is a complex consisting of at least five glycoprotein chains, each having a molecular weight of 20-25kD. The gamma subunit, and probably other subunits, of this molecule are closely associated with the alpha and beta chains of the T cell receptor (TCR) molecule (3). The CD3/TCR complex is responsible for the recognition of antigens which are expressed in association with the major histocompatibility (MHC) antigens. The CD3 molecule is generally understood to initiate or mediate T cell activation through signals derived from the TCR molecule (4). The CD3 molecule is present on the majority of resting and activated mature T lymphocytes, and has been used extensively to enumerate these cells in human peripheral blood. This molecule is also present on some natural killer (NK) cells. The CD3 molecule is a T cell lineage marker and is present on the majority of mature thymocytes. The expression of CD3 on thymocytes normally follows the expression of CD2, CD5 and CD7.
CD4 monoclonal antibody recognizes the CD4 antigen (11). This antibody may be used, in combination with other indicators, for the diagnosis or prognosis of immunodeficiency diseases, including hypogammaglobulinemia, severe combined immunodeficiency (SCID) and the acquired immunodeficiency disease (AIDS) (14-16). The CD4 antigen domain is generally recognized to contain the binding site for the HIV retrovirus through interaction with the viral envelope glycoprotein (17). Infection of CD4+ T lymphocytes with the HIV virus eventually results in a profound depletion of these cells with the progression of disease. HIV Infected cells continue to serve as a reservoir for the replicating virus. A decrease in the population of CD4+ cells is directly correlated with immune deficit and deterioration in infected patients (18).
CD8 monoclonal antibody recognizes the CD8 antigen (11). This antibody may be used, in combination with other indicators, for the diagnosis or prognosis of immunodeficiency diseases, including, severe combined immunodeficiency (SCID) and the acquired immunodeficiency disease (AIDS) (12-15). The CD8 monoclonal antibody may be useful in the identification of retroviral and other viral infections. An increase in the percentage of CD8+ cells has been observed in cytomegalovirus (CMV) and hepatitis B infections, as well in HIV disease (14-16).
Applications
Suitable for use in Flow Cytometry. Other applications not tested.
Recommended Dilution
Flow Cytometry: Reagent is tested for flow cytometric analysis using 100ul peripheral blood cells or 20ul/10e6 cells.
Storage and Stability
Storage at 4°C, should not be frozen and avoid prolonged exposure to light.
Immunogen
Human CDCD8
Form
Supplied as a liquid in PBS, pH 7.2, 4mg/ml BSA, sucrose NMT 10%, 0.09% sodium azide.
Purity
Purified
Specificity
CD3, CD4, CD8
References
1. Hsu S., Cossman J., Jaffe E.; Lymphocyte subsets in normal human lymphoid tissues. Am. J. |Clin. Path. 80: 21-30, 1983. |2. Morimoto C., Letvin N.L., Distaso J.A., et al.: The cellular basis for the induction of antigen- |specific T8-suppressor cells. Eur. J. Immunol. 16: 198-204, 1986. |3. Kurrle R., Cluster Report: CD3, in Fourth International Workshop And Conference On Human |Leukocyte Differentiation Antigens. pp 290-293, Vienna, 1989. |4. Transy C., Moingeon P.E., Marshall B., et al.: Most murine anti-human CD3 mAb recognize the |human CD3 epsilon subunit. in Fourth International Leukocyte Workshop and Conference On |Human Leukocyte Differentiation Antigens. pp 293-295, Vienna, 1989. |5. Thoman Y., Rogozinski L., Irogoyen O., et al.: Functional analysis of human T cell subsets |defined by monoclonal antibodies. J. Immunol. 128: 1386-1390, 1983. |6. Rogozinski L., Bass A., Glickman E., et al.: The T4 surface antigen is involved in the induction |of helper function. J. Immunol. 132: 735-739, 1984. |7. Moebius U., Cluster Report: CD8 in Fourth International Workshop And Conference On Human |Leukocyte Differentiation Antigens. pp 342-343, Vienna, 1989. |8. Meuer S., Hussey R., Hodgdon J., et al.: Surface structures involved in target recognition by |human cytotoxic T lymphocytes. Science 128: 471-473, 1982. |9. Meuer S., Schlossman S., Reinherz E., Clonal analysis of human cytotoxic T lymphocytes: T4 |and T8 effector T cells recognize products of different major histocompatibility complex regions. |Proc. Soc. Nat. Acad. Sci. USA 79: 4395-4399, 1982 |10. Rimm I., Schlossman S., Reinherz E., Antibody Dependent cellular cytotoxicity and natural- |killer-like activity are medicated by subsets of activated T cells. Clin. Immunol. Immunopath. |21: 134-140, 1981. |11. Fifth International Workshop and Conference On Human Leukocyte Differentiation Antigens, |Leucocyte Typing V, White Cell Differentiation Antigens, Boston, 1993. |12. Reinherz E.L., Cooper M.D., Schlossman S.F., Abnormalities of T cell maturation and regulation |in human beings with immunodeficiency disorders. J. Clin. Invest. 68 : 609-705, 1981. |13. Schmidt R.E., Monoclonal antibodies for diagnosis of immunodeficiencies. Blut 59: 200-206, 1989. |14. deMartini R.M., Parker, J.W., Immunologic alterations in human immunodeficiency virus |infection: A review. J. Clin. Lab. Anal. 3: 56-70, 1989. |15. Tedder T.F., Crain M.J., Kubagawa H., et al.: Evaluation of lymphocyte differentiation in |primary and secondary immunodeficiency diseases. J. Immunol. 135: 1786-1791, 1985. PI: L13005 (Rev 10/08) DCC-08-1089 |16. Buckley R.H., Gard S., Schiff R., et al: T cells and T cell subsets in a large population of patients |with primary immunodeficiency. Birth Defects 19: 187-191, 1983. |17. Maddon P.J., Dalgeish A.G., McDougal J.S., et al.: The T4 Gene Encodes the AIDS Virus |Receptor and is Expressed in the Immune System and the Brain. Cell 47: 383, 1986. |18. Wong-Stael F., Gallo R.C., The family of human T-lymphotropic leukemia viruses: HTLV-I as |the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency |syndrome. Blood 65: 253-263, 1985. |19. Smolen J.S., Morimoto C., Steinberg A.D., et al.: Systemic lupus erythematosus: delineation of |subpopulations by clinical serologic and T cell marker analysis. Am. J. Med. Sci. 289: 139-141, 1985 |20. Morimoto C., Steinberg A.D., Letvin A.L., et al.: A defect of immunoregulatory T cell subsets in |SLE patients demonstrated with anti-2H4. J. Clin. Invest. 79: 762-765, 1987. |21. Duke O., Panayi G.S., Janossy G., et al.: Analysis of T cell subsets in the peripheral blood and |synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann |Rheum Dis. 42: 357-364, 1983. |22. Loken M.L., Brosnan N.N., Back, B.A., Ault K.A.: Establishing optimal lymphocyte gates for |immunophenotyping for flow cytometry. Cytometry 11: 453-459, 1990. |23. 1994 Revised Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with |Human Immunodeficiency Virus Infection, Morbidity And Mortality Weekly Report (MMWR), |Volume 43/No. RR-3, March 4, 1994. |24. Nicholson J.K.A., Green T.A. and Collaborative Laboratories, Selection of anticoagulants for |lymphocyte immunophenotyping. J. Immunol. Methods 165: 31-35, 1993 . |25. Tennant J.R., Evaluation of the Trypan Blue technique for determination of cell viability. |Transplantation 2: 685-694, 1964. |26. Koepke J.A., Landay A.L.: Precision and Accuracy of Absolute Lymphocyte Counts. Clin. |Immunol. and Immunopath. 52: 19-27, 1989. |27. Brown M.C., Hoffman R.A., Kirchanski S., Controls for flow cytometers in hematology and |cellular immunology, Ann. N.Y. Acad. Sci. 468: 93-103, 1986. |28. Durrand R.E., Calibration of flow cytometer detector systems. Cytometry 2: 192-193, 1981. |29. Angadi C.V., Lack of Leu 3A epitopes on T helper (CD4) lymphocytes. J. Clin. Lab. Anal. 4: 193-195, 1990. |30. Takenada T., Kuribayashi K., Nakamine H., Autosomal codominant inheritance and Japanese |incidence of deficiency of OKT4 epitope with lack of reactivity resulting from conformational |change, J. Immunol. 151: 2864-2870, 1993.
USBio References
No references available
Conjugates
Pricing
Order
Proceed to Checkout
Cart Summary
ProductSizeListYour PriceQtyExt Price
Subtotal:Subtotal:
Subtotal:Subtotal:
Total Coupon Savings:Total Coupon Savings:()
Your cart is currently empty.
- Coupon Code
Recently Viewed
  • CD3
    C2254-87P1 Mab
Contact Us

Visit our technical library or contact our support staff to answer your questions.

Telephone:
1-800-520-3011

Library | Contact

Distributors

For customers outside of the United States, please use one of our many distributors.

View Distributors

Payment Methods

We accept the following payment methods as well as pay-by-invoice.

MasterCard Visa PayPal
© 2023-2024 United States Biological - All Rights Reserved